>for up to five years after diagnosis, the use of such drugs has consistently benefited from the cognitive aspect, and the mortality rate has also been reduced. >
EMA is cautious about using regdanvimab to treat COVID-19
Time of Update: 2021-04-13
COVID-19After reviewing the data in the ongoing study, the results showed that Regdanvimab may reduce the hospitalization rate, shorten the recovery time of subjects by at least 3 days, and reduce the incidence of severe illness by 54%.
Loratinib was used in NSCLC patients with treated brain metastases, and the intracranial ORR reached 51.6%!
Time of Update: 2021-03-27
Recently, researchers announced the results of a multi-cohort study aimed at exploring the efficacy and safety of loratinib in the treatment of advanced NSCLC patients who have progressed through the second-generation ALK-TKI treatment.
Express | Topical JAK inhibitors to treat eczema, Incyte uses priority review coupons to submit new drug applications
Time of Update: 2021-03-25
Reference:  Incyte Announces Acceptance and Priority Review of NDA for Ruxolitinib Cream for Atopic Dermatitis.
Cell sub-news reveal: Traditional Chinese medicine ingredients can promote thermogenesis of fat or can be used to treat obesity
Time of Update: 2021-03-25
In the future, drugs that target thermogenesis and metabolism of fat cells, especially Chinese herbal medicine extracts, may become a new approach to obesity treatment, and it is expected that safer and more effective weight-loss drugs will be developed.
Eli Lilly announced that the US government will purchase more doses of neutralizing antibody therapy to treat COVID-19
Time of Update: 2021-03-20
In addition, the National Institutes of Health (NIH) recently updated its COVID-19 treatment guidelines, recommending the use of bamlanivimab in combination with etesevimab to treat patients with mild to moderate COVID-19 who are at high risk of clinical progression.
Cell Heavy: Use probiotics to treat brain diseases and improve social behavior!
Time of Update: 2021-03-17
In a new study published in "Cell" on March 11, Beijing time, a research team led by Baylor College of Medicine found that gut microbes can also cause certain symptoms related to complex neurological diseases.
The study found that an osteoporosis drug could be used to treat hair loss
Time of Update: 2021-03-09
a drug for osteoporosis is expected to be used to treat hair loss problems such as shedding, according to a new study by the University of New Development.
External JAK inhibitor to treat eczema Incyte using priority review vouchers submitted...
Time of Update: 2021-03-07
Retrieved February 19, 2021, from Ruxolitinib Cream: Phase 3 Data in Atopic Dermatitis.
Sickle cell disease (SCD) new drug! The first drug to treat the root causes of the disease, Oxbryta
Time of Update: 2021-03-03
maa sought full approval from the EMA for Oxbryta to treat hemolytic anemia in patients aged 12 years and older with sickle cell disease (SCD).
Cell: Tumor immunotherapy can be used to treat malignant brain cancer
Time of Update: 2021-02-27
February 15, 2021 /--- -- Scientists have identified a new target for a potentially malignant brain tumor immunotherapy, according to a recent paper published in the journal Cell.
NEJM: Avacopan is used to treat ANCA-related vasculitis
Time of Update: 2021-02-26
the researchers conducted a Phase 3 randomized trial (ADVOCATE) that compared the role of avacopan and the d diminishing number of Ponieson in patients with ANCA-related vasculitis who were treated with immunosuppressive drugs at the same time.
Turalio, a new drug used to treat tendon cytoblastoma, has been approved by the FDA for the first time
Time of Update: 2021-02-24
the U.S. Food and Drug Administration (FDA) approved Dayichi Sankyo's Pexidartinib capsule for the treatment of adult patients with tendon cytomoma (TGCT) symptoms, who are associated with severe morbidity or functional limitations and have not improved through surgery.
Navuliyu monoantigen is used to treat the successful treatment of muscle layer immersion urethra cancer after rooting surgery (CheckMate -274 study)
Time of Update: 2021-02-24
CheckMate-274 is a randomized, double-blind, multi-center Phase 3 clinical study designed to assess the efficacy and safety of Odivo (Navuliyu monoanti) compared placebo for patients with high risk of recurrence of muscle-layer immersive urethroid cancer after surgery.
AstraZeneur's clinical late-stage products are expected to be used to treat deadly neurological diseases
Time of Update: 2021-02-14
We believe that in AstraZenecon's Phase 2a study, early signals observed at a 12-week point in time provide a strong reason to initiate a long-term, definitive trial to determine its efficacy and safety in MSA patients.
Stem cells to treat diabetes! I3C/Mitsubishi UFJ/Tokyo University of Technology collaborated on the use of iPSC to create a β pancreas:
Time of Update: 2021-02-12
with induced erythrocyte stem cells (iPSCs) for regenerative medicine and cell therapy. The Kume and Shiraki laboratories at the School of Life Sciences and Technology at Tokyo University of Technology have developed a technology that can produce
Blood: The more cortisol is used, the worse the prognosis for patients with large B-cell lymphoma treated with CAR T cell therapy!
Time of Update: 2021-02-10
Corticosteroids are often used to manage severe toxicity associated with chimic antigen-treated (CAR) T-cell therapy.
JAMA Netw Open: 43.8% of newly diagnosed patients with peripheral diabetic neuropathy (DPN) use opioids to treat pain
Time of Update: 2021-02-03
patients with combined arthritis are less likely to use the recommended medications in the guidelines.
Scientists used a non-toxic Botox drug delivery platform to treat Botox poisoning
Time of Update: 2021-02-02
efficiently target motor neurons and nerve endings, general therapeutic drugs cannot enter neurons, so once paralysis occurs, you can only wait for these toxins to slowly disappear, there is no better treatment to reverse the process. Recently